Tonix Pharmaceuticals Holding said the Food and Drug Administration has accepted its application seeking approval of its TNX-102 SL product candidate for the chronic pain condition fibromyalgia.
A major breakthrough in our understanding of pain has been revealed in a collaborative study led by a Leeds scientist, opening the door to new ways of tackling long term pain without harmful and ...
Just when you thought the opioid crisis may have peaked, Dr. Andrew Kolodny, arguably the world’s foremost anti-opioid zealot, has found a shiny new way to inflate the numbers. In the HHS’s redefining ...